ARMAZENAGEM REOPRO
Cuidados de Armazenamento: O medicamento deve ser mantido de 2 a 8 ºC. Não congelar. Não
agitar. Desprezar a porção não usada.
Prazo de validade: NUNCA USE QUALQUER MEDICAMENTO COM O PRAZO DE VALIDADE
VENCIDO. O prazo de validade do produto é de 36 meses e a data de validade está impressa no cartucho.
- REFERÊNCIAS
1. Tcheng J, Ellis SG, George BS. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin
antiplatelet antibody Fab 7E3 in high risk coronary angioplasty. Circulation; 1994; 90: 1757-
1764.
2. Simoons ML de Boer MJ, van der Brand MJBM, et al. Randomized trial of a GPIIb/IIIa platelet
receptor blocker in refractory unstable angina1. Circulation; 1994; 89:596-603.
3. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein
IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
4. Topol EJ, Califf RM, Weisman HF, et al. Randomised trial of coronary intervention with
antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six
months. Lancet 1994: 343: 881-886.
5. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin
during percutaneous coronary revascularization. N Eng J Med. 1997; 336: 1689-1696.
6. CAPTURE Investigators. Randomised placebo2-controlled trial of abciximabe before, during and
after coronary intervention in refractory unstable angina1: the CAPTURE study. Lancet 1997;
349: 1429-1435.
7. Rao, AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial - Phase I:
Hemorrhagic manifestations and changes in plasma3 fibrinogen and the fibrinolytic system in
patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll
Cardiol 1988;11: 1-11.
8. Landefeld, CS, Cook EF, Flatley M, et al. Identification and preliminary validation of predictors
of major bleeding in hospitalized patients starting anticoagulant therapy. Am. J Med. 1987;
82:703-713.
REGISTRO MS - 1.1260.0010
VENDA SOB PRESCRIÇÃO MÉDICA - USO RESTRITO A HOSPITAIS
Farm. Resp.: Dalton Nivoloni CRF-SP Nº. 11422
Fabricação, validade e número de lote, vide rótulo e cartucho
Fabricado por: Parkedale Pharmaceuticals Inc., Rochester - MI, EUA
Embalado por: Cilag AG, Schaffhausen, Suíça
Distribuído por: Eli Lilly do Brasil Ltda.
Av. Morumbi, 8264 São Paulo - SP
CNPJ 43.940.618/0001-44
Complementos
